Showing results (111-120 of 214) with videos related to
Sort By:
Pageof 22
Cancer Metastasis Reviews|September 9, 2021
Targeting KRAS in pancreatic cancer: new drugs on the horizonSahar F Bannoura, Md Hafiz Uddin, Misako Nagasaka, et al.Molecular Cancer Therapeutics|January 8, 2017
Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal AdenocarcinomaAmro Aboukameel, Irfana Muqbil, William Senapedis, et al.International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancerEdgar Ben-Josef, Anthony F Shields, Ulka Vaishampayan, et al.American Journal of Translational Research|September 10, 2011
Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanismAsfar S Azmi, Shadan Ali, Sanjeev Banerjee, et al.American Journal of Clinical Oncology|October 7, 2006
A phase II study of docetaxel, doxorubicin, and infusional 5-fluorouracil in the treatment of patients with locally advanced breast cancerLata Chandi Thatai, Priya Vishnubhotla, Laura Biernat, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Phase II study of erlotinib in patients with advanced biliary cancerPhilip A Philip, Michelle R Mahoney, Cristine Allmer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancerPhilip A Philip, Michelle R Mahoney, Cristine Allmer, et al.Cancer Treatment Reviews|June 5, 2019
Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidenceThomas Seufferlein, Pascal Hammel, Jean Robert Delpero, et al.Oncology|October 18, 2017
An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)Jordan D Berlin, Yang Feng, Paul Catalano, et al.Cancer Metastasis Reviews|April 20, 2021
Gastrointestinal stromal tumor: a review of current and emerging therapiesBayan Al-Share, Abdulrahman Alloghbi, Mohammed Najeeb Al Hallak, et al.Pageof 22